Ultimately, it should be noted that the use of TIMP-2*IGFBP-7 has been approved primarily for the early detection of AKI, and its use for predicting RRT so far remains an off-label application but is subject of investigations [21]. This evidence concerns the gene IGFBP7 and acute kidney injury.